Drug profile · INN
ceftriaxone sodium
CEFTRIAXONE
ceftriaxone sodium (CEFTRIAXONE) is a bacterial penicillin-binding protein inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — ceftriaxone sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 2
- Programs
- 13
- Data quality
- 0.89
Quick answer
ceftriaxone sodium (CEFTRIAXONE) is a bacterial penicillin-binding protein inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is ceftriaxone sodium?
ceftriaxone sodium (CEFTRIAXONE) is a bacterial penicillin-binding protein inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for ceftriaxone sodium?
CEFTRIAXONE is a marketed brand name for ceftriaxone sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ceftriaxone sodium?
ceftriaxone sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.